Discovered by BIOTEC research team together with the Medicines for Malaria Venture (MMV), the patented P218 compound was designed based-on 3-dimensional structures of malaria protein target, dihydrofolate reductase, in order to circumvent mutations that had led to resistance to pyrimethamine, […]
Recent Posts
- Delegation of U.S. Department of Agriculture (USDA) visited National Center for Genetic Engineering and Biotechnology (BIOTEC)
07/10/2024 - Congratulations to BIOTEC Researchers Awarded Borlaug Fellowships, United States Department of Agriculture (USDA)
07/09/2024 - Brazil Cassava Growers’ delegation from the State of Parana, Brazil visited BIOTEC
07/05/2024